February 16, 2025 – Health Technology Net

Independent Pharmacy Cooperative (IPC) and Legacy Pharmacy Group (LPG) Announce Strategic Cooperation Agreement

Staff February 16, 2025

SUN PRAIRIE, Wis., Feb. 16, 2025 /PRNewswire/ -- Independent Pharmacy Cooperative (IPC), the leading Group Purchasing Organization (GPO) for independent pharmacies...

Day: February 16, 2025

Independent Pharmacy Cooperative (IPC) and Legacy Pharmacy Group (LPG) Announce Strategic Cooperation Agreement

Bahrain Makes History with First Successful CRISPR-Based Sickle Cell Treatment Outside the US

Smartee Pioneers a New Phase in Orthodontics with Silicon Valley Founder Mode

Brii Bio Unveils New Data from Its Ongoing Phase 2 ENSURE Study at APASL 2025, Showcasing BRII-179’s Unique Potential to Prime and Boost Higher HBsAg Loss Through Target Patient Identification

Anthos Therapeutics Shares New Data from the Landmark AZALEA-TIMI 71 Study Demonstrating the Factor XI Inhibitor Abelacimab Significantly Reduced Bleeding in Patients Regardless of Age or Bleeding Risk

ProDentim Reviews (EXPOSED): Why 75,000+ Americans Are Replacing Mouthwash with This ProDentim Chewable Tablet

Novo Nordisk A/S: Rybelsus® (oral semaglutide 14 mg) demonstrates superior reduction in cardiovascular events in the SOUL trial at ACC 2025

Independent Pharmacy Cooperative (IPC) and Legacy Pharmacy Group (LPG) Announce Strategic Cooperation Agreement

Bahrain Makes History with First Successful CRISPR-Based Sickle Cell Treatment Outside the US

You may have missed

Smartee Pioneers a New Phase in Orthodontics with Silicon Valley Founder Mode

Brii Bio Unveils New Data from Its Ongoing Phase 2 ENSURE Study at APASL 2025, Showcasing BRII-179’s Unique Potential to Prime and Boost Higher HBsAg Loss Through Target Patient Identification

Anthos Therapeutics Shares New Data from the Landmark AZALEA-TIMI 71 Study Demonstrating the Factor XI Inhibitor Abelacimab Significantly Reduced Bleeding in Patients Regardless of Age or Bleeding Risk

ProDentim Reviews (EXPOSED): Why 75,000+ Americans Are Replacing Mouthwash with This ProDentim Chewable Tablet

Novo Nordisk A/S: Rybelsus® (oral semaglutide 14 mg) demonstrates superior reduction in cardiovascular events in the SOUL trial at ACC 2025